Merkel cell carcinoma in a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab

REFERENCES

• Linjawi A, Janison WB, Meterissian S. Merkel cell carcinoma: important aspect of diagnosis and management. Am Surg 2001;67:943–947.
   Google Scholar
• Lehrer MS, Hershock D, Ming ME. Merkel cell carcinoma. Curr Treat Options Oncol 2004;5:195–198.
   PubMedGoogle Scholar
• Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002;20:588–598.
   PubMed Web of Science ®Google Scholar
• Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prey 1999;8:53–158.
   PubMed Web of Science ®Google Scholar
• Shack RB, Barton RM, DeLozier J, Rees RS, Lynch JB. Is aggressive surgical management justified in the treatment of Merkel cell carcinoma? Plast Reconstr Surg 1994;94:970–975.
   Google Scholar
• Tennvall J, Biocrklund A, Johansson I, Akerman M. Merkel cell carcinoma: management of primary, recurrent and metastatic disease: a clinicopathological study of 17 patients. Eur J Surg Oncol 1989;15:1–9.
   PubMed Web of Science ®Google Scholar
• Yiengpruksavan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma. Prognosis and manage-ment. Arch Surg 1991;126:1514–1519.
   Google Scholar
• Robak T. Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia. Hematology 2004;9:387–400.
   PubMedGoogle Scholar
• Agnew KL, Ruchlemer R, Catovsky D, Matutes E, Bunker CB. Cutaneous finding in chronic lymphocytic leukemia. Br J Dermatol 2004;150:1129–1135.
   Google Scholar
• Ziprin P, Smith S, Salerno G, Rosin RD. Two cases of Merkel cell tumour arising in patients with chronic lymphocytic leukemia. Br J Dermatol 2000;42:525–528.
   Web of Science ®Google Scholar
• Quaglino D, Di Leonardo G, Lalli G et al. Association between chronic lymphocytic leukemia and secondary tu-mours: unusual occurrence of a neuroendocrine (Merkel cell) carcinoma. Eur Rev Med Pharm Sci 1997;1:11–16.
   PubMedGoogle Scholar
• Safadi R, Pappo 0, Okon E, Sviri S, Eldor A. Merkel cell tumor in a woman with chronic lymphocytic leukemia. Leuk Lymphoma 1996;20:509–511.
   PubMed Web of Science ®Google Scholar
• Warakaulle DR, Rytina E, Burrows NP. Merkel cell tumour associated with chronic lymphocytic leukaemia. Br J Dermatol 2001;144:216–217.
   Google Scholar
• Vlad R, Woodlock TJ. Merkel cell carcinoma after chronic lymphocytic leukemia: case report and literature review. Am J Clin Oncol 2003;26:531–534.
   PubMed Web of Science ®Google Scholar
• Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219–234.
   PubMed Web of Science ®Google Scholar
• Robak T, Blotiski JZ, Kasznicki M et al. Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia. Hematol J 2002;3:244–250.
   PubMedGoogle Scholar
• Cheson BD, Bennett JM, Greyer M et al. National Cancer Institute Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990–4997.
   PubMed Web of Science ®Google Scholar
• Robak T, Smolewski P, Urbanska-Ryg H, Göra-Tybor J, Eihniski JZ, Kasznicki M. Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies. Leuk Lymphoma 2004;45:937–944.
   Google Scholar
• Chan JK, Suster S, Wenig BM, Tsang WY, Chab JB, Lau AL. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997;21:226–234.
   PubMed Web of Science ®Google Scholar
• Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial and Merkel cell carcinomas. Mod Pathol 1995;8:384–388.
   PubMed Web of Science ®Google Scholar
• Schmidt U, Muller U, Metz KA, Leder LD. Cytokeratin and neurofilament protein staining in Merkel cell carcinoma of the small cell type and small cell carcinoma of the lung. Am J Dermatopathol 1998;20:346–351.
   PubMed Web of Science ®Google Scholar
• Banerjee SS, Agbamu DA, Eyden BP, Harris M. Clinico-pathological characteristics of peripheral primitive neuroectodermal tumour of the skin and subcutaneous tissue. Histopathology 1997;31:355–366.
   PubMed Web of Science ®Google Scholar
• Nicholson SA, McDermott MB, Swanson PE, Wick MR CD99 and cytokeratin 20 in small-cell and basaloid tumors of the skin. Appl Immunohistochem Mol Morphol 2000;8:37–41.
   PubMedGoogle Scholar
• Brady MS. Current management of patients with Merkel cell carcinoma. Dermatol Surg 2004;30:321–325.
   PubMed Web of Science ®Google Scholar
• Linjawi A, Jamison WB, Metrissian S. Merkel cell carcinoma: important aspects of diagnosis and management. Am Surg 2001;67:943–947.
   Google Scholar
• Tennvall J, Biorklund A, Johansson L, Akerman M. Merkel cell carcinoma: management of primary, recurrent and metastatic disease. A clinicopathological study of 17 patients. Eur J Surg Oncol 1989;15:1–9.
   PubMed Web of Science ®Google Scholar
• Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma. Prognosis and manage-ment. Arch Surg 1991;126:1514–1519.
   Google Scholar
• An KP, Ratner D. Merkel cell carcinoma in the setting of HIV infection. J Am Acad Dermatol 2001;45:309–312.
   PubMed Web of Science ®Google Scholar
• Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys 1995;31:315 — 323.
   Google Scholar
• Catlett JP, Todd WM, Carr ME Jr. Merkel cell tumor in an HIV-positive patient. Va Med Q 1992;119:256–258.
   Google Scholar
• Miller J, Huhn K, Goldman G, Dzubow L. Merkel cell carcinoma in a stem cell transplant patient. Dermatol Surg 1998;24:913–914.
   PubMed Web of Science ®Google Scholar
• Penn I, First MR Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999;68:1717 —1721.
   Google Scholar
• Bartik MM, Welker D, Kay NE. Impairments in immune cell function in B-cell chronic lymphocytic leukemia. Semin Oncol 1998;25:27 — 33.
   Google Scholar
• Seymour JF, Kurzrock R, Freireich EJ, Estey EH. 2-Chlorodeoxyadenosine induces durable remissions and pro-longed suppression of CD4 + lymphocyte counts in patients with hairy cell leukemia. Blood 1994;83:2906— 2911.
   Google Scholar
• Cohen Y, Amir G, Polliack A. Development and rapid dissemination of Merkel-cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphoma. Eur J Hematol 2002;8:117–119.
   Google Scholar
• Ott MJ, Tanabe KK, Gadd MA et al. Multimodality management of Merkel cell carcinoma. Arch Surg 1999;139:388–392.
   Web of Science ®Google Scholar
• Gillenvater AM, Hessel AC, Morrison WH et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001;127:149–154.
   PubMed Web of Science ®Google Scholar
• Meeuwissen JA, Bourne RG, Kearsley JH. The importance of post operative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1995;31:325— 331.
   Google Scholar
• Veness MJ, Morgan GJ, Gebski V. Adjuvant locoregional radiotherpy as best practice in patients with Merkel cell carcinoma of the head and neck. Head Neck 2005;27:208 — 216.
   Google Scholar